 |
|
|
 |
High blood cholesterol - What you need to know
This brochure provides information about how to lower a cholesterol level
that is too high. Lowering a cholesterol level that is too high helps to
reduce the risk for heart disease. Includes a tool to estimate the risk for having a heart attack, and outlines ways to reduce risk. Also contains a list of resources for further information.
more
|
|
Update on FDA's continuing investigation of particulate matter in blood
shows normal blood components and no evidence for an increase in adverse
events
This statement provides an update to the ongoing investigations of
reports of unusual particulate matter in some blood components, primarily red
blood cells (RBCs). Although the cause of the particulate matter is not yet
fully explained, there is no evidence it poses a threat to blood safety at this time. more
|
|
|
|
Download NHLBI's spreadsheet-based, 10-year, heart disease risk assessment tool
This downloadable Excel spreadsheet, developed by Boston University, uses
recent data from the Framingham Heart Study to estimate 10-year risk for
"hard" coronary heart disease outcomes (myocardial infarction and coronary
death) in adults who do not have heart disease or diabetes. more
|
|
Information for professionals: Quick ALLHAT reference for health care providers
The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack
Trial (ALLHAT) is a long-term, multicenter trial conducted on a large group
of participants ages 55 and older with Stage 1 or Stage 2 hypertension and
at least one other cardiovascular disease (CVD) risk factor. Supported by
the National Heart, Lung, and Blood Institute, ALLHAT includes the largest
clinical study to date to compare the effectiveness of medications to treat
hypertension. ALLHAT also included a cholesterol-lowering study in a subset
of patients participating in the hypertension study. .
more
|
|
Neuropathy is key predictor for amputation risk in diabetic patients
New research reported today by diabetic foot care experts shows that
aggressive screening for evidence of nerve damage and sensory loss
(neuropathy) will identify diabetes patients at the highest risk for severe,
disease-induced foot problems, such as infection-prone skin ulcers and a
debilitating deformity called Charcot foot. Left untreated, these
complications put advanced-stage diabetes patients on a path to a lower-limb
amputation. more
|
|
|
